Fitstry Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: compounded or oral GLP-1 for women 40+, refundable $99 intake
Fitstry scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Fitstry is the GLP-1 weight-loss program of Weightstry, LLC, a LegitScript-certified, cash-pay telehealth practice focused on women 40+. It offers compounded semaglutide and tirzepatide as weekly injections, a daily oral GLP-1 tablet, and microdosing. You begin with a free screening and pay a one-time program fee only if you qualify, refunded if a clinician can't prescribe. The monthly medication price bundles a lab panel, unlimited clinician access, bi-weekly care coaching, a 24/7 Care Line and free discreet shipping. Fitstry serves 49 states; compounded medications are not FDA-approved.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Fitstry
RxSpan MD
Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Fitstry at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Fitstry
Each dimension is scored algorithmically from Fitstry’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $149/mo, Fitstry runs about 12% below the $169 median for GLP-1 providers.
Effectiveness25%
7.6/10Fitstry offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.8/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.7/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-15).
Accessibility10%
5.5/10Fitstry's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.9/10Coaching/nutrition support offered.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Fitstry review
Last checked August 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Fitstry
We walked Fitstry’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Free "See if you qualify" eligibility check first — height, weight, date of birth, sex, and state of residence, framed as clinical dosing input ("your physician uses this to dose safely"). No account or card required to see your results.
- 2You set a goal weight and Fitstry shows a personalized, trial-referenced projection ("Show my timeline") — an evidence-based weight curve drawn from published GLP-1 trials, with an honest "individual results vary with your starting point, protocol, and adherence" note.
- 3A roughly 10-part health-background medical intake follows, opening with a GLP-1 contraindication safety screen (personal or family history of medullary thyroid cancer/MEN2, severe GI conditions, organ transplant on anti-rejection meds, and so on).
- 4You create an account and pay a refundable $99 program fee, charged only if you qualify; a licensed clinician then reviews your history, usually within about 24 hours.
- 5If approved, compounded GLP-1 (semaglutide, tirzepatide, an oral tablet, or microdosing) ships free every 4 weeks; if a clinician can't prescribe, the $99 is refunded in full.
- Pricing is transparent up front: the medication plans (compounded semaglutide from $179/mo and tirzepatide $269/mo on the annual plan; month-to-month runs higher) plus the $99 intake fee are shown before you start intake — no bait-and-switch.
- The $99 program fee is charged only if you qualify and is refunded in full if a clinician can't prescribe ("Approved, or your $99 back"), which keeps signup risk low.
- The eligibility check and projection are free and need no account or card; the real medical intake and payment come afterward — the contraindication screening is a genuine clinical gate, not a rubber-stamp form.
- It is an async model: a clinician reviews your history (usually within ~24 hours) with no synchronous video visit required — faster onboarding than lab-plus-video providers, though the medication is compounded, not an FDA-approved brand.
- The monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly coaching, a 24/7 Care Line, free discreet shipping every 4 weeks, and a nausea rescue kit — no surprise add-ons. Cash-pay; licensed in 49 states.
Fitstry customer support
- Phone
- 1-307-285-3404
- Hours
- 24/7 Care Line
GLP-1 medications Fitstry offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
'Starting at $149 — Compounded semaglutide — the GLP-1 most people have in mind. A weekly shot you do at home.'
'Starting at $199 — Compounded tirzepatide — a dual GLP-1 and GIP option.'
'Starting at $249 — GLP-1 Tablets — one dissolvable tablet per day.' Note the oral form is the DEAREST of the three.
Microdosing options start at $169/mo; the exact price and molecule are confirmed after the free screening.
Ready to get started?
Plans and promotions change often — check Fitstry's current pricing and active discounts before you decide.
What we like
- Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
- Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
- Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
- Runs under Weightstry, LLC, a LegitScript-certified practice with an independently verifiable seal, a named support email and phone
- Full compounded lineup — weekly injection, daily oral tablet and microdosing options
Watch-outs
- Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
- Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
- Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Is Fitstry worth it? Our verdict
Fitstry positions itself around one thing: compounded or oral GLP-1 for women 40+, refundable $99 intake. It runs $149/month — toward the affordable end of the market. Its standout is a needle-free oral option, which very few providers offer.
Beyond the core GLP-1 program, Fitstry leans on Injection, oral & microdose, LegitScript-certified, and Labs + coaching included.
How much Fitstry actually costs
- Compounded semaglutide — $149/month
- Compounded tirzepatide — $199/month
- Compounded GLP-1 (oral) — $249/month
- Compounded semaglutide — $169/month
That puts Fitstry below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Gala (about $149/month) is one of the closest alternatives to weigh Fitstry against.
Medications: what Fitstry prescribes
Fitstry prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Fitstry's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who Fitstry is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- are needle-averse and want a non-injectable option.
- want coaching and follow-up included, not sold separately.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Fitstry earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Fitstry scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Fitstry?
Starting at $149/month. See current pricing and start your free consultation.
Fitstry might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Fitstry review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Fitstry's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.